Vanguard Group Inc Voyager Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.12 Trillion
Q2 2024

A detailed history of Vanguard Group Inc transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,038,564 shares of VYGR stock, worth $17.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,038,564

Previous 3,231,698 5.98%

Holding current value

$17.8 Million

Previous $30.1 Million 20.11%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$7.42 - $10.54 $1.43 Million - $2.04 Million	-193,134 Reduced 5.98%	3,038,564 $24 Million
Q1 2024 May 10, 2024	BUY	$7.15 - $10.84 $5.02 Million - $7.61 Million	702,030 Added 27.75%	3,231,698 $30.1 Million
Q4 2023 Feb 14, 2024	BUY	$6.28 - $8.81 $299,625 - $420,333	47,711 Added 1.92%	2,529,668 $21.4 Million
Q3 2023 Nov 14, 2023	BUY	$7.55 - $11.25 $46,289 - $68,973	6,131 Added 0.25%	2,481,957 $19.2 Million
Q2 2023 Aug 14, 2023	BUY	$6.94 - $13.99 $3.55 Million - $7.15 Million	511,146 Added 26.02%	2,475,826 $28.3 Million
Q1 2023 May 15, 2023	BUY	$6.0 - $10.78 $57,048 - $102,496	9,508 Added 0.49%	1,964,680 $15.1 Million
Q4 2022 Feb 10, 2023	BUY	$4.94 - $6.61 $288,288 - $385,746	58,358 Added 3.08%	1,955,172 $11.9 Million
Q3 2022 Nov 14, 2022	SELL	$5.57 - $7.47 $518,416 - $695,255	-93,073 Reduced 4.68%	1,896,814 $11.2 Million
Q2 2022 Aug 12, 2022	BUY	$4.82 - $10.09 $299,322 - $626,589	62,100 Added 3.22%	1,989,887 $11.8 Million
Q1 2022 May 13, 2022	SELL	$2.75 - $9.44 $396,709 - $1.36 Million	-144,258 Reduced 6.96%	1,927,787 $14.7 Million
Q4 2021 Feb 14, 2022	SELL	$2.47 - $5.55 $224,347 - $504,100	-90,829 Reduced 4.2%	2,072,045 $5.62 Million
Q3 2021 Nov 12, 2021	SELL	$2.63 - $4.12 $16,040 - $25,127	-6,099 Reduced 0.28%	2,162,874 $5.69 Million
Q2 2021 Aug 13, 2021	BUY	$3.94 - $5.44 $8.55 Million - $11.8 Million	2,168,973 New	2,168,973 $8.96 Million

Others Institutions Holding VYGR

# of Institutions

128

Shares Held

36.7M

Call Options Held

48K

Put Options Held

36.2K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $226M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Voyager Therapeutics, Inc. Transaction History